Conversely, the skeletal muscle-cells of insulin-resistant individuals fail to gain competitive advantages under hyperinsulinemia and dispose of significantly less serum glucose (DeFronzo, 1988; DeFronzo and Tripathy, 2009), thereby increasing the availability of glucose to other cell-types. The gene discussed is INS; the disease is hyperinsulinism.